RT Journal Article
SR Electronic
T1 Birth during the COVID-19 pandemic, but not maternal SARS-CoV-2 infection during pregnancy, is associated with lower neurodevelopmental scores at 6-months
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.12.21260365
DO 10.1101/2021.07.12.21260365
A1 Lauren C. Shuffrey
A1 Morgan R. Firestein
A1 Margaret Kyle
A1 Andrea Fields
A1 Carmela Alcántara
A1 Dima Amso
A1 Judy Austin
A1 Jennifer M. Bain
A1 Jennifer Barbosa
A1 Mary Bence
A1 Catherine Bianco
A1 Cristina Fernández
A1 Sylvie Goldman
A1 Cynthia Gyamfi-Bannerman
A1 Violet Hott
A1 Yunzhe Hu
A1 Maha Hussain
A1 Pam Factor-Litvak
A1 Maristella Lucchini
A1 Arthur Mandel
A1 Rachel Marsh
A1 Danielle McBrian
A1 Mirella Mourad
A1 Rebecca Muhle
A1 Kimberly Noble
A1 Anna Penn
A1 Cynthia Rodriguez
A1 Ayesha Sania
A1 Wendy G. Silver
A1 Kally C. O’Reilly
A1 Melissa Stockwell
A1 Nim Tottenham
A1 Martha G. Welch
A1 Noelia Zork
A1 William P. Fifer
A1 Catherine Monk
A1 Dani Dumitriu
YR 2021
UL http://medrxiv.org/content/early/2021/07/15/2021.07.12.21260365.abstract
AB The intrauterine environment strongly influences development. Neurodevelopmental effects of in utero exposure to maternal SARS-CoV-2 infection are widely speculated but currently unknown. The COVID-19 Mother Baby Outcomes (COMBO) initiative was established at Columbia University Irving Medical Center (CUIMC) in New York City to prospectively study the health and wellbeing of infants with and without in utero exposure to maternal SARS-CoV-2 infection. We report findings on 6-month neurodevelopmental outcomes using the parental-report Ages & Stages Questionnaire, 3rd Edition (ASQ-3), from 107 in utero exposed and 131 unexposed full-term infants born between March and December, 2020. We compare these infants to a historical cohort comprised of 62 infants born at CUIMC at least two months prior to the onset of the pandemic. In utero exposure to maternal SARS-CoV-2 infection was not associated with differences on any ASQ-3 subdomain regardless of infection timing or severity, however, infants born during the pandemic had significantly lower scores on gross motor, fine motor, and personal-social subdomains when compared to the historical cohort. Infants born to women who were in the first trimester of pregnancy during the peak of the pandemic in NYC had the lowest personal-social scores. Birth during the pandemic, but not maternal SARS-CoV-2 infection, was associated with differences in neurodevelopmental outcomes at 6-months. These early findings suggest significantly higher public health impact for the generation born during the COVID-19 pandemic than previously anticipated.Competing Interest StatementDrs. Gyamfi-Bannerman, Dumitriu, Stockwell, and Mourad receive funding from the Centers for Disease Control and Prevention for COVID-19-related mother-infant research. Drs. Gyamfi-Bannerman and Dumitriu have pending reimbursement for consulting for Medela Inc.Funding StatementThis study was supported by R01 MH126531 awarded to Drs. Dumitriu, Monk, and Marsh, gift funding from Einhorn Collaborative to Dr. Welch, P2CHD058486 awarded to Drs. Fifer, Alcantara, and Zork through the Columbia Population Research Center from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, an award to Dr. Shuffrey from the Rita G. Rudel Foundation, and an early career award to Dr. Firestein from the Society for Research in Child Development.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures were approved by the Columbia University Institutional Review Board or the New York State Psychiatric Institute Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available on request through formal submission to the COVID-19 Mother Baby Outcomes (COMBO) Study Maternal-Child Research Oversight (MACRO) Committee.